Detection of the new SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 in five SARS-CoV-2 rapid antigen tests (RATs), Germany, March 2021.

B.1.1.7 B.1.351 Rapid antigen test(s) SARS-CoV-2 Variant(s) of Concern performance

Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
04 2021
Historique:
entrez: 23 4 2021
pubmed: 24 4 2021
medline: 29 4 2021
Statut: ppublish

Résumé

SARS-CoV-2 variants of concern (VOC) should not escape molecular surveillance. We investigated if SARS-CoV-2 rapid antigen tests (RATs) could detect B.1.1.7 and B.1.351 VOCs in certain laboratory conditions. Infectious cell culture supernatants containing B.1.1.7, B.1.351 or non-VOC SARS-CoV-2 were respectively diluted both in DMEM and saliva. Dilutions were analysed with Roche, Siemens, Abbott, nal von minden and RapiGEN RATs. While further studies with appropriate real-life clinical samples are warranted, all RATs detected B.1.1.7 and B.1.351, generally comparable to non-VOC strain.

Identifiants

pubmed: 33890568
doi: 10.2807/1560-7917.ES.2021.26.16.2100413
pmc: PMC8063588
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Bernadett Bartha-Dima (B)
Katja Bengs (K)
Anja Berger (A)
Kerstin Boll (K)
Anja Carl (A)
Christian Jürgen (C)
Juliana Drdlicek (J)
David Eisenberger (D)
Jennifer Flechsler (J)
Lars Gerdes (L)
George Githure (G)
Janani Govindaswamy (J)
Christine Hupfer (C)
Regina Konrad (R)
Gaia Lupoli (G)
Johannes Lutmayr (J)
Gabriele Margos (G)
Roswitha Müller (R)
Silke Nickel (S)
Mercy Okeyo (M)
Melanie Pavlovic (M)
Sven Pecoraro (S)
Isabel Sahm (I)
Melanie Schauer (M)
Anika Schülein (A)
Eva-Maria Schürmann (EM)
Gesine Schulze (G)
Nelly Scuda (N)
Stefanie Singer (S)
Thorsten Stellberger (T)
Bianca Treis (B)
Christian Tuschak (C)
Pia Zimmermann (P)
Natali Paravinja (N)

Commentaires et corrections

Type : ErratumIn

Références

PeerJ. 2021 Jan 4;9:e10666
pubmed: 33505806
J Clin Med. 2021 Jan 17;10(2):
pubmed: 33477365
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Virol J. 2020 Oct 21;17(1):160
pubmed: 33087160
N Engl J Med. 2020 Nov 26;383(22):e120
pubmed: 32997903
Lancet Microbe. 2021 Apr 7;:
pubmed: 33846704
Eur J Clin Microbiol Infect Dis. 2021 Jan 29;:
pubmed: 33512617

Auteurs

Sabrina Jungnick (S)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.
These authors contributed equally to this work.

Bernhard Hobmaier (B)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.
These authors contributed equally to this work.

Lena Mautner (L)

Unit of molecular biologic analytics and biogenetics, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Mona Hoyos (M)

Unit of molecular biologic analytics and biogenetics, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Maren Haase (M)

Unit of molecular biologic analytics and biogenetics, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Armin Baiker (A)

Unit of molecular biologic analytics and biogenetics, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Heidi Lahne (H)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Ute Eberle (U)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Clara Wimmer (C)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Sabrina Hepner (S)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Annika Sprenger (A)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Carola Berger (C)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Alexandra Dangel (A)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Manfred Wildner (M)

Ludwig Maximilians-Universität, Munich, Germany.
Bavarian State Institute of Health, Oberschleißheim, Germany.

Bernhard Liebl (B)

Ludwig Maximilians-Universität, Munich, Germany.
Bavarian State Institute of Health, Oberschleißheim, Germany.

Nikolaus Ackermann (N)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.

Andreas Sing (A)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.
Ludwig Maximilians-Universität, Munich, Germany.

Volker Fingerle (V)

Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.
Public Health Microbiology Unit, Bavarian Health and Food Safety Authority, Oberschleißheim, Germany.
Members of the Bavarian SARS-CoV-Public Health Laboratory Team are listed below.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH